We are live on ! Find out more
BC

Brahman Capital Portfolio holdings

AUM $275M
1-Year Est. Return 18.08%
This Fund
S&P 500
This Quarter Est. Return
+1.07%
1 Year Est. Return
+18.08%
3 Year Est. Return
+16.57%
5 Year Est. Return
+65.78%
10 Year Est. Return
+289.43%
AUM
$1.05B
AUM Growth
-$361M
Cap. Flow
-$356M
Cap. Flow %
-33.82%
Top 10 Hldgs %
95.67%
Holding
15
New
2
Increased
1
Reduced
10
Closed
2

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$111M
2
HLT icon
Hilton Worldwide
HLT
+$66.1M
3
IQV icon
IQVIA
IQV
+$41.8M
4
CLVT icon
Clarivate
CLVT
+$35.4M
5
TIF
Tiffany & Co.
TIF
+$33.4M

Sector Composition

Rank Sector Weight
1 Communication Services 21.93%
2 Technology 20.56%
3 Utilities 20.07%
4 Healthcare 12.82%
5 Financials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRG icon
1
NRG Energy
NRG
$27.2B
$211M 20.07%
6,007,933
-370,244
-6% -$14M
IQV icon
2
IQVIA
IQV
$34.4B
$135M 12.82%
837,751
-297,666
-26% -$41.8M
GDDY icon
3
GoDaddy
GDDY
$12.5B
$134M 12.79%
1,916,650
-255,097
-12% -$19.2M
CHTR icon
4
Charter Communications
CHTR
$16.2B
$116M 10.99%
292,381
-85,690
-23% -$32.1M
FOXA icon
5
Fox Class A
FOXA
$24.2B
$115M 10.94%
3,138,538
+602,538
+24% +$22.1M
ATH
6
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$100M 9.51%
2,322,932
-732,398
-24% -$31.6M
CLVT icon
7
Clarivate
CLVT
$1.53B
$62.9M 5.98%
4,090,298
-2,534,702
-38% -$35.4M
TIF
8
DELISTED
Tiffany & Co.
TIF
$61.6M 5.86%
658,320
-336,501
-34% -$33.4M
BCO icon
9
Brink's
BCO
$4.95B
$45.5M 4.33%
560,868
-129,812
-19% -$10.3M
CCC.WS
10
DELISTED
Clarivate Analytics Plc Warrants, each to purchase one Ordinary Share
CCC.WS
$25.1M 2.38%
5,275,777
-2,913,631
-36% -$10.9M
CCX.U
11
DELISTED
Churchill Capital Corp II
CCX.U
$20.3M 1.93%
+2,000,000
New +$20.3M
EEFT icon
12
Euronet Worldwide
EEFT
$3.1B
$18.8M 1.79%
+111,846
New +$17.1M
GMHIU
13
DELISTED
Gores Metropoulos, Inc. Unit
GMHIU
$6.41M 0.61%
612,166
-929,432
-60% -$9.59M
HLT icon
14
Hilton Worldwide
HLT
$73.1B
-795,557
Closed -$66.1M
TEVA icon
15
Teva Pharmaceuticals
TEVA
$37.3B
-7,064,540
Closed -$111M

Similar funds

Brahman Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Brahman Capital held 15 positions worth $1.05B, down 26% from $1.41B the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Brahman Capital withdrew a net $356M in Q2 2019, closing 2 positions and reducing 10 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $111M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 22% of assets, up from 16% a quarter earlier, followed by Technology and Utilities.

Against the trend, Brahman Capital opened a new position in Churchill Capital Corp II worth $20.3M.

  • Brahman Capital's largest Q2 2019 buy was Churchill Capital Corp II: 2,000,000 shares worth $20.3M.
  • Brahman Capital added most to Fox Class A in Q2 2019, an estimated $22.1M increase.
  • Brahman Capital's biggest Q2 2019 reduction was IQVIA, cutting an estimated $41.8M.
  • Brahman Capital fully exited Teva Pharmaceuticals in Q2 2019, selling an estimated $111M.
  • Brahman Capital's ten largest holdings make up 96% of its $1.05B portfolio in Q2 2019.
  • Brahman Capital opened 2 new positions and closed 2 in Q2 2019.
  • Brahman Capital's portfolio value fell 26% quarter-over-quarter to $1.05B.

Based on Brahman Capital's 13F filing for Q2 2019, filed 14 Aug 2019.